Boehringer Ingelheim

Germany
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

By complying with the HRC’s controversial demands, Boehringer increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Boehringer uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Boehringer supports the Equality Act. The company opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Boehringer Ingelheim receives a High Risk rating.

View Full Corporate Bias Ratings Report
Generate Reports
Clear
Toast